Tulin F. Tuglular - Publications

Real-World Treatment Patterns and Safety Outcomes of Targeted Therapies in a Single-Center Chronic Lymphocytic Leukemia Cohort.

Journal: Medicina (Kaunas, Lithuania)

Published: February 28, 2026

Second-line use of dasatinib and nilotinib in a real-world patient population with chronic phase chronic myeloid leukemia.

Journal: Hematology (Amsterdam, Netherlands)

Published: March 18, 2025

Impact of autologous stem cell transplantation on survival outcomes in patients with peripheral T cell lymphoma.

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

Published: February 12, 2022

Shoulder-Pad Sign in a Case of Amyloidosis Associated with Myeloma

Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology

Published: May 20, 2021

Real-life ruxolitinib experience in intermediate-risk myelofibrosis.

Journal: Blood research

Published: May 18, 2021

Evaluation of clinical characteristics of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab in Turkey: a multicenter retrospective analysis.

Journal: American journal of blood research

Published: April 02, 2021

Study for the Diagnostic Screening of Paroxysmal Nocturnal Hemoglobinuria in Older Patients with Unexplained Anemia and/or Cytopenia.

Journal: Clinical laboratory

Published: September 09, 2020

Hydroxychloroquine-Associated Thrombotic Thrombocytopenic Purpura

Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology

Published: July 25, 2020

Patterns of Hydroxyurea Prescription and Use in Routine Clinical Management of Polycythemia Vera: A Multicenter Chart Review Study

Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology

Published: February 21, 2020

Early Access Program Results From Turkey and a Literature Review on Daratumumab Monotherapy Among Heavily Pretreated Patients With Relapsed/Refractory Myeloma.

Journal: Clinical lymphoma, myeloma & leukemia

Published: January 06, 2020

MERGE: A Multinational, Multicenter Observational Registry for Myeloproliferative Neoplasms in Asia, including Middle East, Turkey, and Algeria.

Journal: Cancer medicine

Published: November 18, 2019

Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience.

Journal: Annals of hematology

Published: August 04, 2019